9121 POSTER A Multi-center, Open, Randomized, Phase II Study to Investigate the Sequential Administration of Docetaxel and Intermittent Erlotinib Versus Erlotinib as a Second-line Therapy for Advanced Non-small Cell Lung Cancer (NSCLC)

✍ Scribed by Aparisi, F.; Sánchez, A.; Giner, V.; Mufioz, J.; Esquerdo, G.; Garde, J.; Garcia, J.; Lopez, A.; Juan, O.

• Book ID: 122705578
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 43 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72433-9